CD4+ T effectors specific for the tumor antigen NY-ESO-1 are highly enriched at ovarian cancer sites and coexist with, but are distinct from, tumor-associated Treg

Cancer immunology research

Volumn 1, Issue 5, 2013, Pages 303-308

  Ayyoub, Maha ^a   Pignon, Pascale ^a   Classe, Jean Marc ^a   Odunsi, Kunle ^a   Valmori, Danila ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CTAG1B PROTEIN, HUMAN; MEMBRANE PROTEIN; TUMOR ANTIGEN;

FEMALE; HUMAN; IMMUNOLOGY; OVARY TUMOR; REGULATORY T LYMPHOCYTE;

ANTIGENS, NEOPLASM; FEMALE; HUMANS; MEMBRANE PROTEINS; OVARIAN NEOPLASMS; T-LYMPHOCYTES, REGULATORY;

EID: 84896294304     PISSN: None     EISSN: 23266074     Source Type: Journal    
DOI: 10.1158/2326-6066.CIR-13-0062-T     Document Type: Article

References (0)